PGRN Best Practices in Clinical Implementation of PGx

Disease Specific Pharmacogenetics Implementation
Moderator:  Ron H.N. van Schaik, PhD

"CYP2C19 Testing in Pst-Myocardial Infarction Patients:
The Shands Experience"

             
Ellen Keeley, MD
Division of Cardiovascular Medicine
University of Florida

"Pharmacogenetics in oncology: preventing adverse events"

Sander Bins, MD, PhD,
AIOS interne
Erasmus Medical College
Netherlands